Related Experiment Videos
[From hypertension to heart failure-a pathophysiological continuum].
1Innere Medizin III, Medizinische Universitätsklinik und Poliklinik der Universität des Saarlandes, Homburg/Saar. kilter@med-in.uni-sb.de
Herz
|May 29, 2004
Summary
Heart failure is a common chronic disease, often caused by hypertension or myocardial infarction. Understanding the signaling pathways in cardiac hypertrophy is key to developing new heart failure treatments.
Area of Science:
- Cardiology
- Molecular Biology
- Physiology
Context:
- Heart failure is a prevalent chronic disease in Western countries with a poor prognosis.
- Aging populations will increase the incidence and importance of heart failure.
- Hypertension and myocardial infarction are primary causes, accounting for ~75% of cases.
Purpose:
- To explore the mechanisms of cardiac hypertrophy induced by pressure overload.
- To investigate the role of neuroendocrine systems, including the renin-angiotensin-aldosterone system and sympathetic nervous system.
- To identify maladaptive signaling pathways in the transition from compensated hypertrophy to heart failure.
Summary:
- Pressure overload in hypertension increases cardiac wall stress, leading to cardiomyocyte hypertrophy.
- Cardiac hypertrophy is triggered by mechanical stress and neuroendocrine activation.
- Myocardial hypertrophy is an independent risk factor for cardiovascular events and a predictor of heart failure.
Impact:
- Identifying maladaptive signaling pathways is crucial for developing novel therapeutic strategies.
- This research aims to improve the prevention and management of heart failure.
- Understanding these pathways can lead to targeted treatments for heart failure patients.